Price (delayed)
$1.66
Market cap
$46.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.86
Enterprise value
$43.67M
OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address
There are no recent dividends present for OSTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.